Wells Fargo Starts Calithera Biosciences (CALA) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Citi Starts Calithera Biosciences (CALA) at Buy
October 27, 2014 8:45 AM EDTCiti initiated coverage on Calithera Biosciences (NASDAQ: CALA) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Calithera Biosciences click here. For more ratings news on Calithera Biosciences click here.
Shares of Calithera Biosciences closed at $11.04 yesterday.
... MoreLeerink Swann Starts Calithera Biosciences (CALA) at Outperform
October 27, 2014 7:10 AM EDTLeerink Swann initiated coverage on Calithera Biosciences (NASDAQ: CALA) with an Outperform rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Calithera Biosciences click here. For more ratings news on Calithera Biosciences click here.
Shares of Calithera Biosciences closed at $11.04 yesterday.
... More


